Table III.
Major cardiovascular events during hospitalisation after anticoagulant-associated clinically relevant, non-major bleeding.
| Type of CV event | Gender/age (years) | Indication for anticoagulants | Type of drug | Site of bleeding | Procoagulants/transfusions | Interruption of the drug | Time from bleeding (days) | Death |
|---|---|---|---|---|---|---|---|---|
| Acute coronary syndrome | M | Non-valvular | VKA | Lower gastrointestinal (rectal) | None/none | Yes | 1 | No |
| 70 | AF | |||||||
|
| ||||||||
| F | Non-valvular | VKA | Upper gastrointestinal (haematemesis) | None/none | Yes | 1 | No | |
| 87 | AF | |||||||
|
| ||||||||
| F | Non-valvular | DOAC | Lower gastrointestinal (rectal) | None/none | Yes | 1 | Yes | |
| 90 | AF | |||||||
|
| ||||||||
| F | VTE | VKA | Muscle haematoma | Vit K/none | Yes | 2 | No | |
| 83 | ||||||||
|
| ||||||||
| M | Non-valvular | VKA | Haemoptysis | Vit K/none | Yes | 1 | Yes | |
| 77 | AF | |||||||
|
| ||||||||
| Ischaemic stroke | M | Other | VKA | Epistaxis | None/none | Yes | NA | No |
| 82 | ||||||||
|
| ||||||||
| Systemic embolism | M | Non-valvular | VKA | Upper gastrointestinal (haematemesis) | Vit K/none | Yes | 2 | No |
| 82 | AF | |||||||
CV: cardiovascular; AF: atrial fibrillation; VTE: venous thromboembolism; VKA: vitamin K antagonist; DOAC: direct oral anticoagulant; Vit K: vitamin K; NA: not available.